Jazz Pharmaceuticals Director Bruce C. Cozadd sells $1.3 million in common shares
- Jazz Pharmaceuticals director Bruce C. Cozadd sold 6,000 ordinary shares on Nov. 2, 2026, at $215.84 per share.
- The Nov. 4, 2026, filing reported direct ownership of 339,875 ordinary shares following the sale.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193210-26-000030), on November 04, 2026, and is solely responsible for the information contained therein.